Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

BP19780c

LGALS3BP Blocking Peptide (Center)

Abcepta

DETAILS

  • Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
  • Gene Id: 3959
  • Category: Peptides; Blocking Peptides
  • Subtitle: Synthetic peptide
  • Gene Name: LGALS3BP
  • Other Names: Galectin-3-binding protein, Basement membrane autoantigen p105, Lectin galactoside-binding soluble 3-binding protein, Mac-2-binding protein, MAC2BP, Mac-2 BP, Tumor-associated antigen 90K, LGALS3BP, M2BP
  • Availability: 2 weeks
  • Bio Background: The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS3BP has been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV). It appears to be implicated in immune response associated with natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity. Using fluorescence in situ hybridization the full length 90K cDNA has been localized to chromosome 17q25. The native protein binds specifically to a human macrophage-associated lectin known as Mac-2 and also binds galectin 1.
  • Bio References: Davila, S., et al. Genes Immun. 11(3):232-238(2010) Srirajaskanthan, R., et al. Mol. Cell Proteomics 9(4):656-666(2010) Zambelli, D., et al. Int. J. Cancer 126(1):41-52(2010) Lee, J.H., et al. Pathology 41(3):229-233(2009) Kim, S.J., et al. Acta Haematol. 120(4):211-216(2008)
  • Other Accession: NP_005558.1
  • Primary Accession: Q08380
  • Targetspecificity: The synthetic peptide sequence is selected from aa 398-412 of HUMAN LGALS3BP